Aortyx is a recently launched company that is developing novel endovascular solutions to aortic diseases providing high value through extensive expertise in cardiovascular devices.

Our first family of products offers endogenous regeneration of the aorta instead of artificial replacement in the unattended aortic dissection indication (>$450M market).